# FMT and Fiber in Patients With Metabolic Syndrome

> **NCT03727321** · PHASE2 · COMPLETED · sponsor: **University of Alberta** · enrollment: 68 (actual)

## Conditions studied

- Obesity
- Metabolic Syndrome

## Interventions

- **COMBINATION_PRODUCT:** Fecal Microbial Transplant
- **DIETARY_SUPPLEMENT:** Fiber
- **DIETARY_SUPPLEMENT:** Cellulose

## Key facts

- **NCT ID:** NCT03727321
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-01
- **Primary completion:** 2020-01-16
- **Final completion:** 2020-01-16
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2020-05-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03727321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03727321, "FMT and Fiber in Patients With Metabolic Syndrome". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT03727321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
